Symbols / LNAI Stock $4.00 +40.60% Lunai Bioworks Inc.

Healthcare • Biotechnology • United States • NCM
LNAI (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. David H. Weinstein
Exch · Country NCM · United States
Market Cap 18.14M
Enterprise Value 11.16M
Income -128.28M
Sales 20.94K
FCF (ttm) -6.96M
Book/sh -2.14
Cash/sh 0.70
Employees 29
Insider 10d —
IPO Feb 07, 2018
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E —
PEG —
P/S 865.99
P/B -1.87
P/C —
EV/EBITDA -1.14
EV/Sales 532.66
Quick Ratio 0.16
Current Ratio 0.19
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -61.52
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-05-15
ROA -9.65%
ROE -3.25%
ROIC —
Gross Margin 100.00%
Oper. Margin -68.15%
Profit Margin 0.00%
Shs Outstand 4.53M
Shs Float 3.35M
Insider Own 31.30%
Instit Own 2.76%
Short Float 8.72%
Short Ratio 0.41
Short Interest 345.11K
52W High 31.04
vs 52W High -87.11%
52W Low 1.21
vs 52W Low 231.13%
Beta 0.36
Impl. Vol. 25.00%
Rel Volume 14.81
Avg Volume 1.78M
Volume 26.30M
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom None
Prev Close $2.85
Price $4.00
Change 40.60%
About

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$4.00
Latest analyst target
3. DCF / Fair value
$-27.65
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.00
Low
—
High
—
Mean
—
News
RSS: Latest LNAI news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-01-21 VAN TILBURG MAURICE Director — 250,000 — —
2024-10-14 WEINSTEIN DAVID HERSHEL Chief Executive Officer — 250,000 — —
2024-07-29 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 1,114 $1.30 $1,448
2024-07-19 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 94,526 $1.51 $142,827
2024-07-17 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 16,362 $1.46 $23,889
2024-07-15 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 21,954 $1.41 $30,955
2024-07-15 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 21,954 $1.41 $30,955
2024-07-11 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 14,896 $1.51 $22,493
2024-07-05 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 110,000 $1.51 $168,500
2024-07-02 WILLIAM ANDERSON WITTEKIND Beneficial Owner of more than 10% of a Class of Security — 94,553 $1.54 $146,812
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Gross Profit
—
0.00
0.00
—
Operating Expense
18.55
-32.28%
27.39
+39.76%
19.60
-14.15%
22.83
Research And Development
0.54
-80.16%
2.71
-34.97%
4.17
-50.25%
8.37
Selling General And Administration
17.88
-27.19%
24.56
+60.32%
15.32
+6.90%
14.33
General And Administrative Expense
17.88
-27.19%
24.56
+60.32%
15.32
+6.90%
14.33
Other Gand A
17.88
-27.19%
24.56
+60.32%
15.32
+6.90%
14.33
Total Expenses
18.55
-32.28%
27.39
+39.76%
19.60
-14.15%
22.83
Operating Income
-18.55
+32.28%
-27.39
-39.76%
-19.60
+14.15%
-22.83
Total Operating Income As Reported
-188.97
-131.46%
-81.64
-111.74%
-38.56
+66.78%
-116.08
EBITDA
-177.15
-106.31%
-85.87
-120.95%
-38.86
+65.59%
-112.94
Normalized EBITDA
-18.30
+32.88%
-27.27
-39.95%
-19.48
+13.72%
-22.58
Reconciled Depreciation
0.13
+5.94%
0.12
+7.37%
0.11
-8.17%
0.12
EBIT
-177.28
-106.16%
-85.99
-120.62%
-38.98
+65.53%
-113.06
Total Unusual Items
-158.85
-171.07%
-58.60
-202.38%
-19.38
+78.55%
-90.36
Total Unusual Items Excluding Goodwill
-158.85
-171.07%
-58.60
-202.38%
-19.38
+78.55%
-90.36
Special Income Charges
-158.74
-170.87%
-58.60
-202.40%
-19.38
+78.55%
-90.36
Other Special Charges
—
1.30
—
—
Impairment Of Capital Assets
170.42
+214.13%
54.25
+186.13%
18.96
-79.67%
93.25
Restructuring And Mergern Acquisition
-11.68
-483.18%
3.05
+627.17%
0.42
+114.47%
-2.90
Net Income
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Pretax Income
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Net Non Operating Interest Income Expense
-0.61
+74.97%
-2.43
-244.40%
-0.71
-181.88%
-0.25
Interest Expense Non Operating
0.73
-70.19%
2.43
+244.40%
0.71
+89.61%
0.37
Net Interest Income
-0.61
+74.97%
-2.43
-244.40%
-0.71
-181.88%
-0.25
Interest Expense
0.73
-70.19%
2.43
+244.40%
0.71
+89.61%
0.37
Interest Income Non Operating
0.12
—
—
0.12
Interest Income
0.12
—
—
0.12
Other Income Expense
-158.85
-171.07%
-58.60
-202.38%
-19.38
+78.55%
-90.36
Gain On Sale Of Security
-0.11
—
-0.00
-11422.22%
0.00
Tax Provision
—
—
0.00
-100.00%
0.00
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
+100.00%
-18.97
Net Income Including Noncontrolling Interests
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Net Income From Continuing Operation Net Minority Interest
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Net Income From Continuing And Discontinued Operation
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Net Income Continuous Operations
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Normalized Income
-19.16
+35.77%
-29.82
-46.88%
-20.30
+51.72%
-42.05
Net Income Common Stockholders
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Diluted EPS
-86.40
-18.68%
-72.80
-28.17%
-56.80
+67.13%
-172.80
Basic EPS
-86.40
-18.68%
-72.80
-28.17%
-56.80
+67.13%
-172.80
Basic Average Shares
2.06
+69.27%
1.22
+73.31%
0.70
+7.11%
0.66
Diluted Average Shares
2.06
+69.27%
1.22
+73.31%
0.70
+7.11%
0.66
Diluted NI Availto Com Stockholders
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Depreciation Amortization Depletion Income Statement
0.13
+5.94%
0.12
+7.37%
0.11
-8.17%
0.12
Depreciation And Amortization In Income Statement
0.13
+5.94%
0.12
+7.37%
0.11
-8.17%
0.12
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Assets
8.23
-94.95%
163.13
+179.81%
58.30
-31.11%
84.63
Current Assets
1.05
-47.61%
2.00
-22.13%
2.57
-73.18%
9.57
Cash Cash Equivalents And Short Term Investments
0.48
+117.97%
0.22
-88.24%
1.87
-79.56%
9.17
Cash And Cash Equivalents
0.09
-57.95%
0.22
-88.24%
1.87
-79.56%
9.17
Cash Financial
0.09
-57.95%
0.22
-88.24%
1.87
-79.56%
9.17
Other Short Term Investments
0.39
0.00
—
—
Receivables
0.00
-100.00%
1.11
0.00
—
Other Receivables
—
1.11
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
0.57
-15.38%
0.67
-3.18%
0.69
+75.81%
0.39
Total Non Current Assets
7.18
-95.54%
161.13
+189.10%
55.74
-25.75%
75.07
Net PPE
1.06
-39.76%
1.75
+23.11%
1.42
-18.39%
1.74
Gross PPE
1.76
-24.58%
2.33
+23.43%
1.89
-10.15%
2.10
Accumulated Depreciation
-0.70
-21.41%
-0.58
-24.43%
-0.46
-30.02%
-0.36
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.21
+4.88%
0.20
+13.29%
0.17
+0.00%
0.17
Other Properties
1.33
-30.49%
1.91
+28.14%
1.49
-12.52%
1.70
Leases
0.22
+0.00%
0.22
+0.00%
0.22
+0.00%
0.22
Goodwill And Other Intangible Assets
6.13
-96.15%
159.36
+193.53%
54.29
-25.89%
73.26
Goodwill
5.96
-96.26%
159.33
+1268.82%
11.64
+0.00%
11.64
Other Intangible Assets
0.17
+452.52%
0.03
-99.93%
42.65
-30.78%
61.62
Non Current Prepaid Assets
0.00
-100.00%
0.02
—
—
Other Non Current Assets
—
0.02
-8.70%
0.02
-68.32%
0.07
Total Liabilities Net Minority Interest
29.58
-5.04%
31.15
+164.03%
11.80
-1.79%
12.01
Current Liabilities
29.16
-3.81%
30.31
+174.97%
11.02
+70.88%
6.45
Payables And Accrued Expenses
18.40
+24.65%
14.76
+145.18%
6.02
+147.40%
2.43
Payables
12.56
+32.88%
9.45
+78.38%
5.30
+277.84%
1.40
Accounts Payable
12.56
+32.88%
9.45
+78.38%
5.30
+277.84%
1.40
Current Accrued Expenses
5.84
+10.01%
5.31
+634.45%
0.72
-29.89%
1.03
Current Debt And Capital Lease Obligation
9.75
+231.08%
2.94
-38.89%
4.82
+231.47%
1.45
Current Debt
9.44
+284.98%
2.45
-47.00%
4.62
+285.41%
1.20
Other Current Borrowings
0.24
+0.00%
0.24
—
1.20
Current Capital Lease Obligation
0.31
-36.57%
0.49
+155.17%
0.19
-23.74%
0.25
Other Current Liabilities
1.01
-92.00%
12.61
+6723.56%
0.18
-92.80%
2.56
Total Non Current Liabilities Net Minority Interest
0.42
-49.60%
0.84
+8.61%
0.78
-86.06%
5.56
Long Term Debt And Capital Lease Obligation
0.42
-49.60%
0.84
+8.61%
0.78
-86.06%
5.56
Long Term Debt
—
—
—
4.58
Long Term Capital Lease Obligation
0.42
-49.60%
0.84
+8.61%
0.78
-21.32%
0.99
Other Non Current Liabilities
—
—
—
—
Stockholders Equity
-21.35
-116.18%
131.98
+183.81%
46.50
-35.96%
72.62
Common Stock Equity
-21.35
-116.18%
131.98
+183.81%
46.50
-35.96%
72.62
Capital Stock
0.02
+11.95%
0.02
+148.74%
0.01
+20.16%
0.01
Common Stock
0.02
+11.95%
0.02
+148.74%
0.01
+20.16%
0.01
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
2.22
+14.43%
1.94
+143.38%
0.80
+20.17%
0.66
Ordinary Shares Number
2.22
+14.43%
1.94
+143.38%
0.80
+20.17%
0.66
Additional Paid In Capital
478.28
+2.95%
464.59
+59.90%
290.55
+4.90%
276.99
Retained Earnings
-510.46
-53.54%
-332.46
-36.24%
-244.03
-19.42%
-204.35
Gains Losses Not Affecting Retained Earnings
10.81
+6430.17%
-0.17
-471.74%
-0.03
+1.82%
-0.03
Other Equity Adjustments
10.81
+6430.17%
-0.17
-471.74%
-0.03
+1.82%
-0.03
Total Equity Gross Minority Interest
-21.35
-116.18%
131.98
+183.81%
46.50
-35.96%
72.62
Total Capitalization
-21.35
-116.18%
131.98
+183.81%
46.50
-39.76%
77.20
Working Capital
-28.11
+0.72%
-28.31
-234.75%
-8.46
-371.59%
3.11
Invested Capital
-11.91
-108.86%
134.43
+162.93%
51.13
-34.78%
78.40
Total Debt
10.17
+168.65%
3.79
-32.30%
5.59
-20.27%
7.02
Net Debt
9.34
+318.88%
2.23
-18.90%
2.75
—
Capital Lease Obligations
0.74
-44.79%
1.34
+37.87%
0.97
-21.81%
1.24
Net Tangible Assets
-27.48
-0.35%
-27.38
-251.58%
-7.79
-1123.81%
-0.64
Tangible Book Value
-27.48
-0.35%
-27.38
-251.58%
-7.79
-1123.81%
-0.64
Current Notes Payable
9.19
+316.63%
2.21
-52.30%
4.62
0.00
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Operating Cash Flow
-7.87
+28.23%
-10.97
+6.82%
-11.77
+25.16%
-15.73
Cash Flow From Continuing Operating Activities
-7.87
+28.23%
-10.97
+6.82%
-11.77
+25.16%
-15.73
Net Income From Continuing Operations
-178.01
-101.31%
-88.43
-122.82%
-39.68
+65.02%
-113.43
Depreciation Amortization Depletion
0.13
+5.94%
0.12
+7.37%
0.11
-8.17%
0.12
Depreciation
0.12
+4.96%
0.11
+5.82%
0.11
-1.17%
0.11
Amortization Cash Flow
0.01
+19.36%
0.01
+34.35%
0.01
-58.82%
0.01
Depreciation And Amortization
0.13
+5.94%
0.12
+7.37%
0.11
-8.17%
0.12
Amortization Of Intangibles
0.01
+19.36%
0.01
+34.35%
0.01
-58.82%
0.01
Other Non Cash Items
-9.70
-216.98%
8.29
+732.79%
1.00
+138.31%
-2.60
Stock Based Compensation
3.31
-29.10%
4.67
+32.19%
3.54
-35.62%
5.49
Asset Impairment Charge
170.42
+214.13%
54.25
+186.13%
18.96
-79.67%
93.25
Operating Gains Losses
—
1.30
—
0.02
Unrealized Gain Loss On Investment Securities
0.11
0.00
—
—
Gain Loss On Sale Of PPE
—
—
0.00
-100.00%
0.02
Change In Working Capital
5.86
-33.50%
8.81
+104.68%
4.31
+204.23%
1.42
Change In Receivables
1.15
+204.11%
-1.11
-2409332.61%
0.00
-97.11%
0.00
Change In Prepaid Assets
1.14
+5.64%
1.08
+1.12%
1.07
+132.00%
0.46
Change In Payables And Accrued Expense
3.61
-59.15%
8.83
+166.17%
3.32
+252.16%
0.94
Change In Accrued Expense
0.50
-89.53%
4.77
+923.98%
-0.58
-314.50%
-0.14
Change In Payable
3.11
-23.44%
4.06
+4.17%
3.89
+260.21%
1.08
Change In Account Payable
3.11
-23.44%
4.06
+4.17%
3.89
+260.21%
1.08
Change In Other Current Liabilities
-0.04
-477.20%
0.01
+113.88%
-0.08
-871.20%
0.01
Investing Cash Flow
-0.50
+60.32%
-1.26
-4132.48%
-0.03
-477.46%
-0.01
Cash Flow From Continuing Investing Activities
-0.50
+60.32%
-1.26
-4132.48%
-0.03
-477.46%
-0.01
Net PPE Purchase And Sale
0.00
+100.00%
-0.07
-136.55%
-0.03
-477.46%
-0.01
Purchase Of PPE
0.00
+100.00%
-0.07
-136.55%
-0.03
-477.46%
-0.01
Capital Expenditure
—
-0.07
-136.55%
-0.03
-477.46%
-0.01
Net Investment Purchase And Sale
-0.50
0.00
—
—
Purchase Of Investment
-0.50
0.00
—
—
Net Business Purchase And Sale
0.00
+100.00%
-1.19
0.00
—
Purchase Of Business
0.00
+100.00%
-1.26
0.00
—
Financing Cash Flow
8.38
-20.30%
10.52
+132.94%
4.52
+6.23%
4.25
Cash Flow From Continuing Financing Activities
8.38
-20.30%
10.52
+132.94%
4.52
+6.23%
4.25
Net Issuance Payments Of Debt
6.98
-13.27%
8.05
0.00
+100.00%
-0.56
Issuance Of Debt
6.98
-13.27%
8.05
0.00
—
Repayment Of Debt
—
-0.87
+22.44%
-1.12
-100.01%
-0.56
Long Term Debt Issuance
6.98
-13.27%
8.05
0.00
—
Long Term Debt Payments
—
-0.87
+22.44%
-1.12
-100.01%
-0.56
Net Long Term Debt Issuance
6.98
-13.27%
8.05
0.00
+100.00%
-0.56
Short Term Debt Issuance
—
4.28
0.00
—
Net Short Term Debt Issuance
—
4.28
0.00
—
Net Common Stock Issuance
2.38
-20.79%
3.00
-25.22%
4.01
-14.21%
4.68
Proceeds From Stock Option Exercised
0.00
-100.00%
0.34
-78.96%
1.62
+1104.48%
0.13
Net Other Financing Charges
-0.97
-11.63%
-0.87
+22.44%
-1.12
-100.01%
-0.56
Changes In Cash
0.01
+100.47%
-1.71
+76.48%
-7.29
+36.54%
-11.49
Effect Of Exchange Rate Changes
-0.14
-325.96%
0.06
+816.39%
-0.01
-60.21%
-0.01
Beginning Cash Position
0.22
-88.24%
1.87
-79.56%
9.17
-55.61%
20.66
End Cash Position
0.09
-57.95%
0.22
-88.24%
1.87
-79.56%
9.17
Free Cash Flow
-7.87
+28.68%
-11.04
+6.46%
-11.80
+24.99%
-15.74
Interest Paid Supplemental Data
0.02
+21.99%
0.02
-94.29%
0.35
+341.99%
0.08
Income Tax Paid Supplemental Data
0.00
0.00
0.00
-100.00%
0.00
Common Stock Issuance
2.38
-20.79%
3.00
-25.22%
4.01
-14.21%
4.68
Issuance Of Capital Stock
2.38
-20.79%
3.00
-25.22%
4.01
-14.21%
4.68
Sale Of Business
0.00
-100.00%
0.07
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category